Alan M. Zaslavsky

Alan M. Zaslavsky

Auto-generated profile, based on publicly available information

Alan M. Zaslavsky

Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2014 in Medical Care Research and Review
Verified
Journal Article
Closed access
PDF file
RPRebecca Anhang Price
Rebecca Anhang Price
MEMarc N. Elliott
Marc N. Elliott
AZAlan M. Zaslavsky
Alan M. Zaslavsky
RHRon D. Hays
Ron D. Hays
WLWilliam G. Lehrman
William G. Lehrman
PCPaul D. Cleary
Paul D. Cleary
Patient care experience surveys evaluate the degree to which care is patient-centered. This article reviews the literature on the association between patient experiences and other measures of health care quality. Research indicates that better patient care experiences are associated with higher levels of adherence to recommended prevention and treatment processes, better clinical outcomes, better patient safety within hospitals, and less health care utilization. Patient experience measures that are collected using psychometrically sound instruments, employing recommended sample sizes and adjustment procedures, and implemented according to standard protocols are intrinsically meaningful and are appropriate complements for clinical process and outcome measures in public reporting and pay-for-performance programs.

18 May 2010 in Medical Decision Making
Verified
Journal Article
Open access
PDF file
CRCarolyn M. Rutter
Carolyn M. Rutter
AZAlan M. Zaslavsky
Alan M. Zaslavsky
EFEric J. Feuer
Eric J. Feuer
Background . Microsimulation models (MSMs) for health outcomes simulate individual event histories associated with key components of a disease process; these simulated life histories can be aggregated to estimate population-level effects of treatment on disease outcomes and the comparative effectiveness of treatments. Although MSMs are used to address a wide range of research questions, methodological improvements in MSM approaches have been slowed by the lack of communication among modelers. In addition, there are few resources to guide individuals who may wish to use MSM projections to inform decisions. Methods . This article presents an overview of microsimulation modeling, focusing on the development and application of MSMs for health policy questions. The authors discuss MSM goals, overall components of MSMs, methods for selecting MSM parameters to reproduce observed or expected results (calibration), methods for MSM checking (validation), and issues related to reporting and interpreting MSM findings(sensitivity analyses, reporting of variability, and model transparency). Conclusions . MSMs are increasingly being used to provide information to guide health policy decisions. This increased use brings with it the need for both better understanding of MSMs by policy researchers, and continued improvement in methods for developing and applying MSMs.

8 March 2019 in Health Services Research
Verified
Journal Article
Closed access
PDF file
KMKaren E. Joynt Maddox
Karen E. Joynt Maddox
MRMat Reidhead
Mat Reidhead
JHJianhui Hu
Jianhui Hu
AKAmy J. H. Kind
Amy J. H. Kind
AZAlan M. Zaslavsky
Alan M. Zaslavsky
DNDavid R. Nerenz
David R. Nerenz

1 June 2018 in Health Affairs
Verified
Journal Article
Closed access
RHRebecca L. Haffajee
Rebecca L. Haffajee
MMMichelle M. Mello
Michelle M. Mello
FZFang Zhang
Fang Zhang
AZAlan M. Zaslavsky
Alan M. Zaslavsky
MLMarc R. Larochelle
Marc R. Larochelle
JWJ. Frank Wharam
J. Frank Wharam
State prescription drug monitoring programs (PDMPs) aim to reduce risky controlled-substance prescribing, but early programs had limited impact. Several states implemented robust features in 2012–13, such as mandates that prescribers register with the program and regularly check its registry database. Some states allow prescribers to fulfill the latter requirement by designating delegates to check the registry. The effects of robust PDMP features have not been fully assessed. We used commercial claims data to examine the effects of implementing robust PDMPs in four states on overall and high-risk opioid prescribing, comparing those results to trends in similar states without robust PDMPs. By the end of 2014 the absolute mean morphine-equivalent dosages that providers dispensed declined in a range of 6–77 mg per person per quarter in the four states, relative to comparison states. Only in one of the four states, Kentucky, did the percentage of people who filled opioid prescriptions decline versus its compa...

1 October 2000 in Medical Care
Verified
Journal Article
Closed access
AZAlan M. Zaslavsky
Alan M. Zaslavsky
JHJohn N. Hochheimer
John N. Hochheimer
ESEric C. Schneider
Eric C. Schneider
PCPaul D. Cleary
Paul D. Cleary
JSJoshua J. Seidman
Joshua J. Seidman
AEArnold M. Epstein
Arnold M. Epstein
The widely used Health Plan Employer Data and Information Set (HEDIS) measures may be affected by differences among plans in sociodemographic characteristics of members. The objective of this study was to estimate effects of geographically linked patient sociodemographic characteristics on differential performance within and among plans on HEDIS measures. Using logistic regression, we modeled associations between age, sex, and residential area characteristics of health plan members and results on HEDIS measures. We then calculated the impact of adjusting for these associations on plan-level measures. This study included 92,232 commercially insured members with individual-level HEDIS data and an additional 20,615 members whose geographic distribution was provided. This study used 7 measures of screening and preventive services. Performance was negatively associated with percent receiving public assistance in the local area (6 of 7 measures), percent black (5 measures), and percent Hispanic (2 measures) and positively associated with percent college educated (6 measures), percent urban (2 measures), and percent Asian (1 measure) after controlling for plan and product type. These effects were generally consistent across plans. When measures were adjusted for these characteristics, rates for most plans changed by less than 5 percentage points. The largest change in the difference between plans ranged from 1.5% for retinal exams for people with diabetes to 20.2% for immunization of adolescents. Performance on quality indicators for individual members is associated with sociodemographic context. Adjustment has little impact on the measured performance of most plans but a substantial impact on a few. Further study with more plans is required to determine the appropriateness and feasibility of adjustment.

19 April 2012 in Health Services Research
Verified
Journal Article
Closed access
PDF file
AZAlan M. Zaslavsky
Alan M. Zaslavsky
JAJohn Z. Ayanian
John Z. Ayanian
LZLawrence B. Zaborski
Lawrence B. Zaborski